Hikal shows 17% degrowth in Q1 FY23

Pharmaceutical sales de-grew 18% YoY and stood at Rs. 224 crore whereas Crop Protection sales de-grew by 15% at Rs. 154 crore

Ube to buy API Corp. from Mitsubishi Chemical

APIC is a contract development and manufacturing organization (CDMO) that offers a wide range of services such as synthetic route design, pilot manufacturing, investigational medical manufacturing, and commercial production, by making full use of integrated processes that combine organic synthesis technologies and biotechnologies it has cultivated over many years

Merck KGaA posts higher earnings, profits across business segments

Despite the price increases for raw materials and logistics, EBITDA pre rose organically by 3.2% to € 1,782 million

BioIVT promotes Dr. Richard Haigh to CEO

Healthcare Triangle launches in Singapore; Leveraging AI and cloud in Asia Pacific Markets

The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.

WuXi AppTec plans to build a new site in Singapore

Better serving global partners and advancing healthcare innovation

Merck opens microbiology application lab in Jigani, Bengaluru

Merck’s first microbiology application and training lab in India

Brii Bio inks partnership with China Resources Pharmaceutical to advance the commercialization of Long-acting COVID-19 neutralizing antibody therapy

The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China

Biotium introduces new line of antibodies for exosome detection

ExoBrite antibody conjugates are validated and optimized for bright and specific detection of exosome markers

Evonik now offers enteric protected ready to fill capsules EUDRACAP in IPEC-GMP quality

Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals